Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The impact of the number of induction cycles required to achieve first complete remission (CR1) on transplant outcomes in adult acute lymphoblastic leukemia (ALL) patients remains unknown. We conducted a retrospective EBMT registry analysis (2000-2022) of ALL patients who underwent transplantation in CR1 after one (n = 2038), two (n = 296), or three or more (n = 110) induction cycles. Median age was 40 years (range 18-73); 79% had B-ALL. At 2 years, relapse incidence was 23%, 31%, and 32%, while non-relapse mortality was 17%, 18%, and 16%, for those achieving CR1 after one, two, and ≥3 cycles, respectively. Multivariable analysis showed that requiring ≥2 cycles was associated with increased relapse risk. Leukemia-free survival (LFS) at 2 years was 60%, 51%, and 52%, and overall survival (OS) was 68%, 61%, and 60%, for patients needing one, two, and ≥3 cycles, respectively. Multivariable analysis confirmed significantly worse LFS and OS in patients requiring multiple cycles versus one. These findings suggest that the number of induction cycles to achieve CR1 is a key prognostic factor for post-transplant outcomes in adult ALL and support the development of risk-adapted strategies in this setting.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-025-02669-0DOI Listing

Publication Analysis

Top Keywords

induction cycles
16
cycles
8
post-transplant outcomes
8
number induction
8
outcomes adult
8
cycles multivariable
8
multivariable analysis
8
patients
5
impact pre-transplant
4
induction
4

Similar Publications

Objective: To present a case of metastatic endometrial carcinosarcoma (ECS) with a long-term complete response to chemotherapy using a paclitaxel and carboplatin regimen.

Case Report: A 47-year-old premenopausal woman was diagnosed with a large, advanced intrauterine tumor. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy.

View Article and Find Full Text PDF

Transient Induction of Chirality from an Activated Carboxylic Acid to a Zinc Complex.

Angew Chem Int Ed Engl

September 2025

Dipartimento di Chimica and Istituto CNR per i Sistemi Biologici (ISB-CNR), Sezione Meccanismi di Reazione, c/o Dipartimento di Chimica, Università di Roma "La Sapienza", P.le A. Moro 5, Rome, I-00185, Italy.

Enantiomerically pure activated carboxylic acids (ACAs), (R)- and (S)-2-cyano-2-phenylpropanoic acids, are exploited to program the induction of chirality onto a zinc metal complex over time. NMR analysis shows that binding of the enantiopure ACA conjugate base to the Zn center breaks the symmetry of the complex and induces the formation of a single diastereoisomeric metal complex. Such a diastereoisomer is present only as long as the ACA is found in solution, and the ACA loading determines the time interval in which it persists in solution.

View Article and Find Full Text PDF

Despite the success of antiretroviral therapy in suppressing plasma viremia in people living with human immunodeficiency virus type-1 (HIV-1), persistent viral RNA expression in tissue reservoirs is observed and can contribute to HIV-1-induced immunopathology and comorbidities. Infection of long-lived innate immune cells, such as tissue-resident macrophages and microglia may contribute to persistent viral RNA production and chronic inflammation. We recently reported that de novo cytoplasmic expression of HIV-1 intron-containing RNA (icRNA) in macrophages and microglia leads to MDA5 and MAVS-dependent innate immune sensing and induction of type I IFN responses, demonstrating that HIV icRNA is a pathogen-associated molecular pattern (PAMP).

View Article and Find Full Text PDF

3-O-acetylrubiarbonol B preferentially targets EGFR and MET over rubiarbonol B to inhibit NSCLC cell growth.

PLoS One

September 2025

Department of Biomedicine, Health and Life Convergence Sciences, BK21 Four, College of Pharmacy, Mokpo National University, Muan, Republic of Korea.

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related deaths, remaining a significant challenge in terms of early detection, effective treatment, and improving patient survival rates. In this study, we investigated the anticancer mechanism of rubiarbonol B (Ru-B) and its derivative 3-O-acetylrubiarbonol B (ARu-B), a pentacyclic terpenoid in gefitinib (GEF)-sensitive and -resistant NSCLC HCC827 cells. Concentration- and time-dependent cytotoxicity was observed for both Ru-B and ARu-B.

View Article and Find Full Text PDF

Introduction: Several studies indicate that a specific genotype profile could influence ovarian sensitivity to exogenous gonadotropin. However, most of the previous studies were observational and retrospective and thereby more prone to bias. The aim of this study was to evaluate the impact of gonadotropin single nucleotide polymorphisms (SNPs) on the outcomes of fertilization (IVF) in infertile patients undergoing their first ovarian stimulation (OS) cycle.

View Article and Find Full Text PDF